Medicortex Finland Oyj

Medicortex Finland Oyj company information, Employees & Contact Information

Updated June 2026

Quick answer

Medicortex Finland Oyj is a Biotechnology Research company and founded in 2014. It has approximately 13 employees on record. Contact data was last refreshed in June 2026. Find Medicortex Finland Oyj's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Medicortex Finland Oyj is a biotechnology company dedicated to developing diagnostics and treatments for acute neurodegenerative conditions, including traumatic brain injury (TBI) and concussion. The company is currently focusing on the development of a rapid test, based on a proprietary biomarker, for detection of TBI and concussion. Medicortex was founded by Dr. Adrian Harel in Turku, Finland, in 2014 and it operates as a public limited company. Dr. Harel has a track record in business management and leadership of early-stage biotechnology companies. ---- Kuvaus suomeksi: Medicortex Finland Oyj (http://www.medicortex.fi) on bioteknologian alan yritys, joka on keskittynyt parantamaan tapaturmaisten aivovammojen (TBI) diagnostiikkaa ja hoitoa. Yrityksen nykyinen painopiste on kehittää biomerkkiaineisiin perustuvaa diagnostiikkaa, jolla pystytään arvioimaan aivovamman laajuutta ja vaikeusastetta.

Company Details

Employees
13
Founded
2014
Address
Itäinen Pitkäkatu 4 B, 4th Floor,finland
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Turku, Southwest Finland
Looking for a particular Medicortex Finland Oyj employee's phone or email?

Medicortex Finland Oyj Questions

News

A patent granted for Medicortex - STT Info

A patent granted for Medicortex STT Info

Glymphatic system and mild traumatic brain injury: a mini review - Frontiers

Glymphatic system and mild traumatic brain injury: a mini review Frontiers

Medicortex Finland Plc signed a 1.4 million dollars research grant contract with the U.S. Department of Defense - STT Info

Medicortex Finland Plc signed a 1.4 million dollars research grant contract with the U.S. Department of Defense STT Info

Dr Adrian Harel Of Medicortex Proposes A Multi-Functional Drug Approach For The Treatment Of Traumatic Brain Injury (TBI) - Life Science Leader

Dr Adrian Harel Of Medicortex Proposes A Multi-Functional Drug Approach For The Treatment Of Traumatic Brain Injury (TBI) Life Science Leader

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant